New search | Conferencedetail
Print view
 
 

Synthetic Lethality Conference, Boston, 2017

evvnt Platform / evvnt
Conference themes
Across 3 content-packed days, the field’s thought leaders from AstraZeneca, Tesaro, Artios, Metabomed, Sierra Oncology and many more will be sharing their insight and lessons learned, collectively enabling the community to:

- Achieve Efficacy across Contexts: Define the key steps required to identify and therapeutically exploit robust synthetic lethal interactions that are conserved across a variety of defined contexts.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Graeme Smith - Chief Scientific Officer - Artios Pharma Ltd., J. Carl Barrett - Vice President of Translational science in Oncology - AstraZeneca and many more.
 

Enquiries and Registration:

https://go.evvnt.com/160417-2
Ms. Charlotte Harrison
 
Categories
General Medicine
Languages
English
Congress fees
USD 4.097,00
(USD 699 - USD 4097)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

FFG - 7. EU-RahmenprogrammCenter of ExcellenceHilfswerk AustriaAGEM - Arbeitsgemeinschaft Ethnomedizin e. V.Charité International AcademyEuropean Health Forum GasteinAnästhesie in Entwicklungsländern e. V.newTree

Facebook

Give us your professional opinion

Start survey

Start survey